<?xml version='1.0' encoding='utf-8'?>
<document id="18399715"><sentence text="Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide."><entity charOffset="25-37" id="DDI-PubMed.18399715.s1.e0" text="ketoconazole" /><entity charOffset="113-124" id="DDI-PubMed.18399715.s1.e1" text="ciclesonide" /><entity charOffset="151-176" id="DDI-PubMed.18399715.s1.e2" text="desisobutyryl-ciclesonide" /><pair ddi="false" e1="DDI-PubMed.18399715.s1.e0" e2="DDI-PubMed.18399715.s1.e0" /><pair ddi="false" e1="DDI-PubMed.18399715.s1.e0" e2="DDI-PubMed.18399715.s1.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s1.e0" e2="DDI-PubMed.18399715.s1.e2" /><pair ddi="false" e1="DDI-PubMed.18399715.s1.e1" e2="DDI-PubMed.18399715.s1.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s1.e1" e2="DDI-PubMed.18399715.s1.e2" /></sentence><sentence text="Cytochrome P450 (CYP) 3A4 isoenzyme has been identified in vitro as the key enzyme to metabolize desisobutyryl-ciclesonide (des-CIC), the pharmacologically active metabolite of the inhaled corticosteroid ciclesonide"><entity charOffset="97-122" id="DDI-PubMed.18399715.s2.e0" text="desisobutyryl-ciclesonide" /><entity charOffset="124-131" id="DDI-PubMed.18399715.s2.e1" text="des-CIC" /><entity charOffset="204-215" id="DDI-PubMed.18399715.s2.e2" text="ciclesonide" /><pair ddi="false" e1="DDI-PubMed.18399715.s2.e0" e2="DDI-PubMed.18399715.s2.e0" /><pair ddi="false" e1="DDI-PubMed.18399715.s2.e0" e2="DDI-PubMed.18399715.s2.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s2.e0" e2="DDI-PubMed.18399715.s2.e2" /><pair ddi="false" e1="DDI-PubMed.18399715.s2.e1" e2="DDI-PubMed.18399715.s2.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s2.e1" e2="DDI-PubMed.18399715.s2.e2" /></sentence><sentence text=" This pharmacokinetic drug-drug interaction study was conducted to confirm this major metabolic pathway in vivo by using the strong CYP3A4 inhibitor ketoconazole, and to assess the effect of ketoconazole on the pharmacokinetics of ciclesonide and des-CIC"><entity charOffset="149-161" id="DDI-PubMed.18399715.s3.e0" text="ketoconazole" /><entity charOffset="191-203" id="DDI-PubMed.18399715.s3.e1" text="ketoconazole" /><entity charOffset="231-242" id="DDI-PubMed.18399715.s3.e2" text="ciclesonide" /><pair ddi="false" e1="DDI-PubMed.18399715.s3.e0" e2="DDI-PubMed.18399715.s3.e0" /><pair ddi="false" e1="DDI-PubMed.18399715.s3.e0" e2="DDI-PubMed.18399715.s3.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s3.e0" e2="DDI-PubMed.18399715.s3.e2" /><pair ddi="false" e1="DDI-PubMed.18399715.s3.e1" e2="DDI-PubMed.18399715.s3.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s3.e1" e2="DDI-PubMed.18399715.s3.e2" /></sentence><sentence text="" /><sentence text="Fourteen healthy adults participated in this open-label, nonrandomized, fixed sequence, two-period, repeated-dose pharmacokinetic study" /><sentence text=" During the first 7-day treatment period, the subjects orally inhaled ciclesonide 320 microg once daily"><entity charOffset="70-81" id="DDI-PubMed.18399715.s6.e0" text="ciclesonide" /></sentence><sentence text=" During the second 7-day treatment period, the subjects continued with the same dose of orally inhaled ciclesonide and concomitantly received oral ketoconazole 400 mg once daily"><entity charOffset="103-114" id="DDI-PubMed.18399715.s7.e0" text="ciclesonide" /><entity charOffset="147-159" id="DDI-PubMed.18399715.s7.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.18399715.s7.e0" e2="DDI-PubMed.18399715.s7.e0" /><pair ddi="false" e1="DDI-PubMed.18399715.s7.e0" e2="DDI-PubMed.18399715.s7.e1" /></sentence><sentence text=" Pharmacokinetic profiles for ciclesonide and des-CIC were obtained on day 7 of each study period"><entity charOffset="30-41" id="DDI-PubMed.18399715.s8.e0" text="ciclesonide" /></sentence><sentence text="" /><sentence text="For the parent compound, ciclesonide, no changes in the pharmacokinetic parameter estimates--the area under the serum concentration-time curve during the dosage interval (AUC(tau)), maximum serum concentration (C(max)) and time to reach the C(max)--were observed"><entity charOffset="25-36" id="DDI-PubMed.18399715.s10.e0" text="ciclesonide" /></sentence><sentence text=" In contrast, the AUC(tau) and C(max) of des-CIC increased approximately 3" /><sentence text="5-fold and 2-fold under the influence of the CYP3A4 inhibitor ketoconazole"><entity charOffset="62-74" id="DDI-PubMed.18399715.s12.e0" text="ketoconazole" /></sentence><sentence text="" /><sentence text="The CYP3A4 pathway is the major pathway for biotransformation of the active metabolite of ciclesonide in humans"><entity charOffset="90-101" id="DDI-PubMed.18399715.s14.e0" text="ciclesonide" /></sentence><sentence text=" While elimination of des-CIC was reduced by strong CYP3A4 inhibitor coadministration in vivo, activation of the parent compound ciclesonide to des-CIC was not affected"><entity charOffset="129-140" id="DDI-PubMed.18399715.s15.e0" text="ciclesonide" /></sentence><sentence text=" Dose adjustment is not necessary when ciclesonide needs to be coadministered with ketoconazole, because the potency of an inhaled corticosteroid is mediated by topical concentrations in the lung and because ciclesonide has a very low potential to produce systemic adverse effects"><entity charOffset="39-50" id="DDI-PubMed.18399715.s16.e0" text="ciclesonide" /><entity charOffset="83-95" id="DDI-PubMed.18399715.s16.e1" text="ketoconazole" /><entity charOffset="131-145" id="DDI-PubMed.18399715.s16.e2" text="corticosteroid" /><entity charOffset="208-219" id="DDI-PubMed.18399715.s16.e3" text="ciclesonide" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e0" e2="DDI-PubMed.18399715.s16.e0" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e0" e2="DDI-PubMed.18399715.s16.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e0" e2="DDI-PubMed.18399715.s16.e2" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e0" e2="DDI-PubMed.18399715.s16.e3" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e1" e2="DDI-PubMed.18399715.s16.e1" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e1" e2="DDI-PubMed.18399715.s16.e2" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e1" e2="DDI-PubMed.18399715.s16.e3" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e2" e2="DDI-PubMed.18399715.s16.e2" /><pair ddi="false" e1="DDI-PubMed.18399715.s16.e2" e2="DDI-PubMed.18399715.s16.e3" /></sentence><sentence text="" /></document>